Genomics and the classification of mental illness: Focus on broader categories

Rudolf Uher

doi:10.1186/gm501

Genomics and the classification of mental illness: Focus on broader categories

Rudolf Uher

Medicine

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

8 Citas (Scopus)

Resumen

Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of severe mental illness may be an important target for future large-scale etiological and therapeutic investigations. Studies of patient groups not restricted to current diagnostic categories may lead to a genetically informed nosology.

Idioma original	English
Número de artículo	97
Publicación	Genome Medicine
Volumen	5
N.º	10
DOI	https://doi.org/10.1186/gm501
Estado	Published - oct. 25 2013

Nota bibliográfica

Funding Information:
RU is supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) and grants from the Canadian Institutes of Health Research, the Nova Scotia Health Research Foundation and the European Commission Innovative Medicine Initiative Joint Undertaking (#115008).

Funding Information:
RU consults for the World Health Organization. He has co-chaired a steering board of a research project, unrelated to the present article, initiated and funded by Bristol Myers Squibb. RU has received no personal income from pharmaceutical or biotech industry and holds no equity in companies active in medicine, pharmaceuticals or biotechnology.

ASJC Scopus Subject Areas

Molecular Medicine
Molecular Biology
Genetics
Genetics(clinical)

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1186/gm501

Otros archivos y enlaces

Citar esto

@article{ff1de1f3cd41407d986a9dc4ac8866e9,

title = "Genomics and the classification of mental illness: Focus on broader categories",

abstract = "Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of severe mental illness may be an important target for future large-scale etiological and therapeutic investigations. Studies of patient groups not restricted to current diagnostic categories may lead to a genetically informed nosology.",

author = "Rudolf Uher",

note = "Funding Information: RU is supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) and grants from the Canadian Institutes of Health Research, the Nova Scotia Health Research Foundation and the European Commission Innovative Medicine Initiative Joint Undertaking (#115008). Funding Information: RU consults for the World Health Organization. He has co-chaired a steering board of a research project, unrelated to the present article, initiated and funded by Bristol Myers Squibb. RU has received no personal income from pharmaceutical or biotech industry and holds no equity in companies active in medicine, pharmaceuticals or biotechnology.",

year = "2013",

month = oct,

day = "25",

doi = "10.1186/gm501",

language = "English",

volume = "5",

journal = "Genome Medicine",

issn = "1756-994X",

publisher = "BioMed Central",

number = "10",

}

TY - JOUR

T1 - Genomics and the classification of mental illness

T2 - Focus on broader categories

AU - Uher, Rudolf

N1 - Funding Information: RU is supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/) and grants from the Canadian Institutes of Health Research, the Nova Scotia Health Research Foundation and the European Commission Innovative Medicine Initiative Joint Undertaking (#115008). Funding Information: RU consults for the World Health Organization. He has co-chaired a steering board of a research project, unrelated to the present article, initiated and funded by Bristol Myers Squibb. RU has received no personal income from pharmaceutical or biotech industry and holds no equity in companies active in medicine, pharmaceuticals or biotechnology.

PY - 2013/10/25

Y1 - 2013/10/25

N2 - Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of severe mental illness may be an important target for future large-scale etiological and therapeutic investigations. Studies of patient groups not restricted to current diagnostic categories may lead to a genetically informed nosology.

AB - Coinciding with the release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, two recently published molecular genetics analyses suggest large overlaps in genetic liability to schizophrenia, bipolar disorder and major depressive disorder. This indicates that a broader category of severe mental illness may be an important target for future large-scale etiological and therapeutic investigations. Studies of patient groups not restricted to current diagnostic categories may lead to a genetically informed nosology.

UR - http://www.scopus.com/inward/record.url?scp=84887954461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887954461&partnerID=8YFLogxK

U2 - 10.1186/gm501

DO - 10.1186/gm501

M3 - Article

AN - SCOPUS:84887954461

SN - 1756-994X

VL - 5

JO - Genome Medicine

JF - Genome Medicine

IS - 10

M1 - 97

ER -

Genomics and the classification of mental illness: Focus on broader categories

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto